Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-09-15
Original SEC Filing: Click here

---

Webplus: SVA/20150915/6-K/2_EX-99.1/000.htm SEC Original: v420222_ex99-1.htm
Sinovac to Participate in Morgan Stanley Global Healthcare Conference BEIJING, September 10, 2015 — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate the Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt Hotel in New York City from Wednesday September 16 to Friday September 18,

---

---

Webplus: SVA/20150915/6-K/3_EX-99.2/000.htm SEC Original: v420222_ex99-2.htm
Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing BEIJING, September 14, 2015 — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it has been selected by the Beijing government to be a supplier of the seasonal influenza vaccine for its 2015 vaccination campaign. The Beijing government plans to order a

---

---

Webplus: SVA/20150915/6-K/1/000.htm SEC Original: v420222_6k.htm
FORM 6-K ————– ———- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v420222_6k.htm FORM 6-K

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-09-15CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085